Tactogen

Tactogen is a biopharma startup based in Palo Alto, California, founded in 2020 by neuroscientist Matthew Baggott and entrepreneur Luke Pustejovsky. The company focuses on developing empathogen medicines, which are designed to promote mental wellness and facilitate emotional connection among individuals. Tactogen's innovative approach centers on creating safer and more effective pharmaceuticals, including novel molecules and drug discovery methods aimed at producing unique emotional states that balance openness and motivation. This research-driven initiative seeks to enhance the efficacy of psychotherapy and other psychological treatments while ensuring that empathogens can be prescribed safely for take-home use.